| Expression pattern: |
UP |
| Associated gene: |
CCND1, AGO2 |
| Associated microRNA: |
miR-545-3p |
| Biological function: |
Promotes proliferation, migration, and invasion of RCC cells; inhibits apoptosis; exosomal transfer from highly malignant RCC cells enhances malignant phenotypes in less malignant RCC cells. |
| Molecular mechanism: |
Exosomal circ-PRKCI acts as an miRNA sponge binding miR-545-3p, thereby regulating CCND1 to promote RCC proliferation. |
| Biological pathway or process: |
proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
Bioinformatics Analysis; RT-qPCR; Nuclear-Cytoplasmic Fractionation; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); Transfection; CCK8; EdU Staining; Annexin V/PI Flow Cytometry; Wound Healing Assay; Transwell Assay; Western Blot; In Vivo Animal Model; H&E Staining; Clinical Sample Validation |
| Clinical significance: |
circ-PRKCI is upregulated in RCC tissues and serum exosomes and may serve as a novel liquid biopsy biomarker. |
| Description: |
circ-PRKCI (hsa_circ_0067934) is upregulated in RCC tissues and serum exosomes and can be transferred from highly malignant Caki-1 cells to less malignant RCC cells via exosomes. It mainly localizes to the cytoplasm and functions as a ceRNA by sponging miR-545-3p to increase CCND1, thereby promoting RCC proliferation; it also enhances migration/invasion and inhibits apoptosis in RCC cells in exosome/circ-PRKCI gain-of-function settings. |
| Confidence score: |
0.7302 |